Radioactive drug shows promise in extending life for men with advanced prostate cancer

NCT ID NCT00699751

Completed Disease control Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This large, completed Phase 3 trial tested whether adding a radioactive drug called Radium-223 to standard care could help men with advanced prostate cancer that had spread to their bones and was no longer responding to hormone therapy. The main goal was to see if the treatment helped patients live longer. The study was stopped early because the results were positive, showing a clear survival benefit for those receiving Radium-223.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Study site

Los Angeles, California, 90048-0750, United States
Study site

Roseville, California, 95661, United States
Study site

Tampa, Florida, 33612-9416, United States
Study site

New Orleans, Louisiana, 70112, United States
Study site

St Louis, Missouri, 63110, United States
Study site

Las Vegas, Nevada, 89169, United States
Study site

Philadelphia, Pennsylvania, 19111-2497, United States
Study site

Liverpool, New South Wales, 2170, Australia
Study site

Randwick, New South Wales, 2031, Australia
Study site

St Leonards, New South Wales, 2065, Australia
Study site

Sydney, New South Wales, 2010, Australia
Study site

Wahroonga, New South Wales, 2076, Australia
Study site

Wollongong, New South Wales, 2521, Australia
Study site

Herston, Queensland, 4006, Australia
Study site

Toowoomba, Queensland, 4350, Australia
Study site

Adelaide, South Australia, 5000, Australia
Study site

Woodville South, South Australia, 5011, Australia
Study site

Hobart, Tasmania, 7000, Australia
Study site

Fitzroy, Victoria, 3065, Australia
Study site

Nedlands, Western Australia, 6009, Australia
Study site

Kortrijk, 8500, Belgium
Study site

Ottignies, 1340, Belgium
Study site

Salvador, Estado de Bahia, 41950-640, Brazil
Study site

Belo Horizonte, Minas Gerais, 30110-090, Brazil
Study site

Rio de Janeiro, Rio de Janeiro, 20551 030, Brazil
Study site

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Study site

Barretos, São Paulo, 14784-400, Brazil
Study site

Piracicaba, São Paulo, Brazil
Study site

São Paulo, São Paulo, 05403-000, Brazil
Study site

Belo Horizonte, 30380490, Brazil
Study site

Edmonton, Alberta, T6G 1Z2, Canada
Study site

London, Ontario, N6A 4G5, Canada
Study site

Ottawa, Ontario, K1H 8L6, Canada
Study site

Toronto, Ontario, M4N 3M5, Canada
Study site

Brno, 65653, Czechia
Study site

Chomutov, 430 12, Czechia
Study site

Olomouc, 77900, Czechia
Study site

Ostrava, 708 52, Czechia
Study site

Plzen - Bory, 305 99, Czechia
Study site

Prague, 140 59, Czechia
Study site

Usti n/Labem, 401 13, Czechia
Study site

La Roche-sur-Yon, 85925, France
Study site

Montbéliard, 25209, France
Study site

Saint-Cloud, 92210, France
Study site

Ulm, Baden-Wurttemberg, 89075, Germany
Study site

Hamburg, Hamburg, 20246, Germany
Study site

Frankfurt am Main, Hesse, 60590, Germany
Study site

Marburg, Hesse, 35043, Germany
Study site

Göttingen, Lower Saxony, 37075, Germany
Study site

Hanover, Lower Saxony, 30625, Germany
Study site

Dortmund, North Rhine-Westphalia, 44137, Germany
Study site

Mainz, Rhineland-Palatinate, 55131, Germany
Study site

Berlin, State of Berlin, 10967, Germany
Study site

Berlin, State of Berlin, 14197, Germany
Study site

Chai Wan, Hong Kong
Study site

Hong Kong, Hong Kong
Study site

Kowloon, Hong Kong
Study site

Beersheba, 8410101, Israel
Study site

Kfar Saba, 4428164, Israel
Study site

Tel Aviv, 6423906, Israel
Study site

Zrifin, 7030000, Israel
Study site

Forlì Cesena, Emilia-Romagna, 47014, Italy
Study site

Reggio Emilia, Emilia-Romagna, 42123, Italy
Study site

Bergamo, Lombardy, 24128, Italy
Study site

Milan, Lombardy, 20162, Italy
Study site

Turin, Piedmont, 10060, Italy
Study site

Alkmaar, 1815 JD, Netherlands
Study site

Nijmegen, 6532 SZ, Netherlands
Study site

Rotterdam, 3015 CE, Netherlands
Study site

Ålesund, TBC, Norway
Study site

Bergen, 5021, Norway
Study site

Bodø, 8092, Norway
Study site

Kristiansand, N-4604, Norway
Study site

Oslo, 0379, Norway
Study site

Oslo, 450, Norway
Study site

Tromsø, 9038, Norway
Study site

Trondheim, 7030, Norway
Study site

Bydgoszcz, 85-165, Poland
Study site

Gliwice, 44-101, Poland
Study site

Kielce, 25-734, Poland
Study site

Krakow, 31-051, Poland
Study site

Luiblin, 20-954, Poland
Study site

Warsaw, 02-781, Poland
Study site

Wroclaw, 50 - 556, Poland
Study site

Wroclaw, 50-981, Poland
Study site

Singapore, 258499, Singapore
Study site

Singapore, 308433, Singapore
Study site

Banská Bystrica, 97517, Slovakia
Study site

Bratislava, 82606, Slovakia
Study site

Bratislava, 83305, Slovakia
Study site

Martin, 03659, Slovakia
Study site

Prešov, 08181, Slovakia
Study site

Trnava, 917 01, Slovakia
Study site

Santiago de Compostela, A Coruña, 15706, Spain
Study site

Barcelona, Barcelona, 08023, Spain
Study site

Barcelona, Barcelona, 8036, Spain
Study site

Barcelona, Barcelona, 8041, Spain
Study site

Córdoba, Córdoba, 14004, Spain
Study site

Alcorcón, Madrid, 28922, Spain
Study site

Pamplona, Pamplona, 31008, Spain
Study site

Valencia, Valencia, 46026, Spain
Study site

Barakaldo, Vizcaya, 48903, Spain
Study site

Zaragoza, Zaragoza, 50009, Spain
Study site

Gothenburg, 413 45, Sweden
Study site

Jönköping, 551 85, Sweden
Study site

Kalmar, 391 85, Sweden
Study site

Malmo, 205 02, Sweden
Study site

Sandviken, 80187, Sweden
Study site

Stockholm, 171 76, Sweden
Study site

Sundsvall, 851 86, Sweden
Study site

Umeå, 901 85, Sweden
Study site

Bristol, Bristol, BS2 8ED, United Kingdom
Study site

Romford, Essex, RM7 0AG, United Kingdom
Study site

Leicester, Leicestershire, LE1 5WW, United Kingdom
Study site

Manchester, Manchester, M20 4BX, United Kingdom
Study site

Bebington, Merseyside, CH63 4JY, United Kingdom
Study site

Nottingham, Nottinghamshire, NG5 1PB, United Kingdom
Study site

Taunton, Somerset, TA1 5DA, United Kingdom
Study site

Ipswich, Suffolk, IP4 5PD, United Kingdom
Study site

Guildford, Surrey, GU2 7XX, United Kingdom
Study site

Sutton, Surrey, SM2 5PT, United Kingdom
Study site

Coventry, Warwickshire, CV2 2DX, United Kingdom
Study site

Birmingham, West Midlands, B15 2TH, United Kingdom
Study site

Belfast, BT9 7AB, United Kingdom
Study site

Brighton, BN2 5BD, United Kingdom
Study site

Cardiff, United Kingdom
Study site

Derby, DE22 3NE, United Kingdom
Study site

Hull, HU16 5JQ, United Kingdom
Study site

Leeds, LS9 7TF, United Kingdom
Study site

Northwood, HA6 2RN, United Kingdom
Study site

Plymouth, PL6 8DH, United Kingdom
Study site

Sheffield, S10 2SJ, United Kingdom
Study site

Southampton, SO16 6YD, United Kingdom
Study site

Wolverhampton, WV10 0QP, United Kingdom

Conditions

Explore the condition pages connected to this study.

BONE METASTASES HORMONE-REFRACTORY PROSTATE CANCER